To diagnose and treat early stages (preclinical) Alzheimer’s disease (AD) patients, we need the body-fluid-based biomarkers that reflect the processes that occur at this stage,
Background: Studies have found that autophagy can promote clearance of Aβ. To promote and maintain the occurrence of autophagy in Alzheimer’s disease (AD) may be
Background: Growing awareness of Alzheimer’s disease (AD) has boosted demand for quick and effective way to screen for memory loss and cognitive decline in a
Dementia and cancer are becoming increasingly common in Western countries. In the last two decades, research has focused on Alzheimer’s disease (AD) and cancers, particularly,